Clinical Trial Update: A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland

View source ↗

Summary

A real-world study in Poland evaluating Vedolizumab for adults with ulcerative colitis or Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Inflammatory Bowel Disease (IBD), Crohn's Disease | Status: COMPLETED